Five Key Takeaways From FDA’s CBD Public Meeting
With CBD projected to be a $450 Million industry in the coming year, FDA hosted a packed house of industry stakeholders last week in a day-long public meeting that was the kickoff of a discussion to determine whether there is a pathway for CBD in ingestible products such as foods and dietary supplements. See our summary of key themes here and check out this podcast episode to hear five key takeaways.
Tags: Cannabidiol (CBD)